ALTIMMUNE ($ALT) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of -$0.27 per share, missing estimates of -$0.25 by $0.02. The company also reported revenue of $30,000, beating estimates of $717 by $29,283.
You can see Quiver Quantitative's $ALT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALTIMMUNE Insider Trading Activity
ALTIMMUNE insiders have traded $ALT stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ALT stock by insiders over the last 6 months:
- JEROME BENEDICT DURSO purchased 12,500 shares for an estimated $51,568
- JOHN GILL purchased 12,500 shares for an estimated $51,249
- WAYNE PISANO purchased 5,000 shares for an estimated $20,410
- DIANE JORKASKY purchased 527 shares for an estimated $2,002
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALTIMMUNE Hedge Fund Activity
We have seen 121 institutional investors add shares of ALTIMMUNE stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,331,039 shares (+52.3%) to their portfolio in Q4 2025, for an estimated $12,025,050
- VANGUARD GROUP INC added 3,117,521 shares (+48.9%) to their portfolio in Q4 2025, for an estimated $11,254,250
- STATE STREET CORP added 1,518,448 shares (+42.2%) to their portfolio in Q4 2025, for an estimated $5,481,597
- JANE STREET GROUP, LLC added 1,503,751 shares (+536.7%) to their portfolio in Q4 2025, for an estimated $5,428,541
- NUVEEN, LLC added 1,041,856 shares (+514.9%) to their portfolio in Q4 2025, for an estimated $3,761,100
- D. E. SHAW & CO., INC. added 983,188 shares (+272.8%) to their portfolio in Q4 2025, for an estimated $3,549,308
- MARSHALL WACE, LLP added 922,777 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,331,224
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALTIMMUNE Analyst Ratings
Wall Street analysts have issued reports on $ALT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/10/2025
To track analyst ratings and price targets for ALTIMMUNE, check out Quiver Quantitative's $ALT forecast page.
ALTIMMUNE Price Targets
Multiple analysts have issued price targets for $ALT recently. We have seen 2 analysts offer price targets for $ALT in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Jonathan Wolleben from Citizens set a target price of $14.0 on 11/07/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $12.0 on 10/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
